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Practice Matters: Screening and Monitoring Hyperlipidemia
Introduction
Faith community nursing is classically described as having seven functions:
health educator, personal health counselor, referral advisor, health advocate,
integrator of faith and health, developer of support groups, and volunteer
coordinator (Patterson, 2003). Faith Community Nurses (FCNs) provides these
functions in a holistic faith-based approach using community immersion. This
provision of care allows insight and understanding of the community served in
urban or rural settings or in developed or developing nations. FCNs are working
within communities to support public health initiatives, communicate guidelines
and recommendations in church bulletins and bulletin boards (Dandridge, 2013).
In the inaugural issue of the International Journal of Faith Community Nursing,
hypertension screening was presented as an avenue of disease prevention and
health promotion education to which FCNs are uniquely qualified to influence
through local interventions. Hyperlipidemia often occurs as a co-morbid
condition in individuals with hypertension, the topic of this issue’s discussion.
The integration of faith and health, counseling, and health education are
the top three interventions in which FCNs influence the life of parishioners
(Dandridge, 2013). This model lends itself well to influence chronic disease
management. Hyperlipidemia, a chronic condition associated with cardiovascular
disease, has significant impact in the health of communities as the leading cause
of death worldwide (World Health Organization [WHO], 2015). Dandridge
(2013) suggests that documentation of clear health outcomes is a necessary
component that quantifies the work being performed by FCNs. Health outcome
documentation and goal setting are enhanced when FCNs are aware of the current
incidence, prevalence, current guidelines for screening, best practices, and
lifestyle changes for chronic disease management.
Objectives:
After reading this article, FCNs will:
1. Be aware of the incidence and prevalence of hyperlipidemia worldwide.
2. Be able to discuss current guidelines from the American Heart Association
and the American College of Cardiology.
3. Be able to describe the role of hyperlipidemia in cardiovascular disease.
4. Be able to discuss best practices for screening for hyperlipidemia in the
community settings.
5. Be able to describe lifestyle changes recommended to reduce cardiovascular
disease risk in adults.
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Epidemiology
It is estimated that elevated lipid levels account for over 2.5 million deaths
annually (WHO, 2014). Hyperlipidemia is associated with about one third of
ischemic heart disease and is a major risk factor for stroke and other
cardiovascular disease in adults worldwide (Mozaffarian et al., 2015; WHO,
2014). In the United States, approximately 31 million adults have elevated lipid
levels and six percent are undiagnosed (Mozaffarian et al., 2015). Adult
hyperlipidemia rates are highest in Europe at over 50%, followed closely by the
Americas at just under 50% (WHO, 2014). Regions with rates less than 25%
were South East Asia and Africa (WHO, 2014). The WHO also associates a
correlation between lipid levels and income (WHO, 2014). Adults living in
countries with the higher incomes have higher lipid levels than adults living in
lower income countries (WHO, 2014).
What are Lipids?
Lipids are an essential waxy substance in the blood which is made both in the
body (endogenous) and ingested (exogenous) in the food we eat (Edwards, 2013;
Mozaffarian, 2015). Lipids are necessary for cell structure and function, as well
as in the manufacturing of bile acids, steroid hormones, and vitamin D (Edwards,
2013). Cholesterol (total cholesterol [TC], high-density cholesterol [HDL-C],
low-density cholesterol [LDL-C]) and triglycerides (TG) are the most frequently
reported components of serum cholesterol (Mozaffarian, 2015).
Elevated serum cholesterol is a risk factor highly associated with
cardiovascular (heart attack) and cerebral vascular (stroke) disease (Mozaffarian,
2015). Other factors to consider when evaluating risk are gender, ethnicity,
family history, tobacco use, hypertension, diabetes mellitus, obesity, and an
inactive lifestyle (Mozaffarian, 2015). The modifiable risk factors are the focus
of reducing risk; smoking cessation, blood pressure control, appropriate weight
for height (BMI 17-25), HgbA1C < 7, and an active lifestyle.
Screening Tools
The U.S. Preventive Services Task Force (USPSTF, 2015) strongly recommends
screening women aged 45 years and older for lipid disorders if they are at
increased risk for coronary artery disease. Men aged 35 years and older are at risk
for lipid disorders and are strongly recommended for lipid screening. Men aged
20 to 35 years should receive lipid screening if they are at increased risk. In both
men and women the risk of cardiovascular disease is increased if they have
diabetes, a previous coronary heart disease or atherosclerosis, a family history of
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cardiovascular disease before 50 years of age in a male relative and/or before 60
years of age in a female relative, tobacco use, hypertension, or a body mass index
of 30 or greater (USPSTF, 2015). The new American College of
Cardiology/American Heart Association [ACC/AHA] (2013) guidelines
recommend the use of the atherosclerotic cardiovascular disease (ASCVD) risk
estimator. The heart risk calculator is available on-line at
http://www.cvriskcalculator.com/ and calculates the 10-year risk of heart disease
or stroke (Stone et al., 2014). This calculator is intended for use in patients with
no previous heart attack or stroke, a LDL of less than 190, and an age between 40
and 79 years.
Testing and Monitoring
Screening tests for hyperlipidemia may be completed either non-fasting or fasting
(Stone et al., 2014) and should include TC, LDL-C and HDL-C. Any abnormal
result should be repeated on a separate occasion and the average of both results
should be considered (USPSTF, 2015). There is no consensus on the appropriate
screening intervals in patients with abnormal results. One option recommended
by the USPSTF (2015) is to complete the screening every five years if the
previous screening is within normal limits.
Lipid Values
In the past, the ACC/AHA has supported the treatment of specific lipid laboratory
values to pre-determined goal values. The 2013 ACC/AHA guideline (Stone et
al., 2013) recommends the assessment of ASCVD risk using a heart risk
calculator and LDL-C and non-HDL-C values (TC minus HDL-C). The
introduction of a statin medication (high-intensity, moderate-intensity, or lowintensity) is determined by the provider based on risk factor assessment and the
need for primary prevention (has not had a cardiovascular event) or secondary
prevention (has had a cardiovascular event) protection for the patient (Stone et al.,
2013). The provider views the results of repeat lipid testing as a measure of
medication and life style change efficacy and will likely evaluate other pertinent
laboratory values specific to the individual patient (Edwards, 2013, Stone et al.,
2013). A comprehensive discussion of the algorithm is outside the scope of this
article, but can be accessed at
http://circ.ahajournals.org/content/129/25_suppl_2/S1.full.pdf+html
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Lifestyle Recommendations and Patient Education
American Heart Association CEO, Nancy Brown published five myths
surrounding the ACC/AHA 2013 cholesterol guidelines. These myths should be
reviewed with the patient and compared to the accurate information (Brown,
2013). Ms. Brown offers the truth for each myth.
Myth 1: Lifestyle choices do not
matter.
Myth 2: The guidelines lead to
unnecessary prescribing of statins.
Myth 3: Pharmaceutical companies
influenced the guideline.
Myth 4: Statins do more harm than
good.
Myth 5: The risk assessment is flawed.

Truth: Lifestyle choices are offered
before and during all other drug
treatment.
Truth: The patient and provider
determine treatment based on risk
reduction benefit.
Truth: None of the ACC/AHA expert
panel were involved with the
pharmaceutical industry.
Truth: Research has shown a reduction
in deaths due to heart attack and stroke
using statins.
Truth: For the first time, the risk
assessment considers individual
ethnicity, age, and gender to assess
specific individual risk.

Lifestyle modifications are the foundation of all treatment of
hyperlipidemia and the prevention of heart attack and stroke. The treatment of
obesity (body mass index > 30) is approached through a healthy diet and regular
exercise, making sure that the individual has consumed fewer calories than
expended through exercise in a day (AHA, October 2014). A diet rich in fresh
fruits and vegetables, lean meats including fish, low in sodium, and high in fiber
is recommended (AHA, April 2015). An active lifestyle for cholesterol reduction
includes 40 minutes of exercise at least 3-4 times a week (AHA, March 2015).
The AHA has published a five-part series which explains the 2013 guidelines for
heart disease and stroke prevention (http://blog.heart.org/new-heart-disease-andstroke-prevention-guidelines-released/).
Conclusions
Screenings for hyperlipidemia, with the goal of reducing cardiovascular diseases,
addresses a significant health issue. Best practices for FCNs involves risk
reduction by addressing modifiable risk factors (tobacco use, hypertension,
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obesity, diabetes, and sedentary lifestyles) through health education. A heart risk
calculator is available on-line to support FCNs assessment and education of
individuals with risk factors. FCNs are positioned to deliver effective lifestyle
modification education to improve the health of the community they serve
through chronic disease screenings.
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